Image
Improving the diagnosis and patient management of systemic autoinflammatory diseases
vidéo
PlayPlay
vidéo
PlayPlay
previous arrow
next arrow

SAID signature

Identify a common signature to SAID enabling rapid differential diagnosis

SAID characterization

Provide deep characterization of each specific pathogenic pathway and build dedicated analysis kits

SAID diagnosis

Build a robust algorithm enabling reliable triage among the whole SAID spectrum

 

What are guSAID?

Find out more on the different kind of auto-inflammatory disease for which diagnosis is missing

 

 

Find a center!

Identify the recruitment centre closest to you

 

 

Follow the science

Discover the current hot topics that are investigated in the SAID field

 

 Consortium presentation

The ImmunAID consortium (Immunome project consortium for AutoInflammatory Disorders), coordinated by INSERM, is composed of 25 partners in 12 countries and includes clinical centres and academic research laboratories but also patients representatives and SMEs as well as ECRIN.

Project Management Team (PMT)

The project management team is supporting the coordinator for the whole coordination and management of the consortium but also the communication on the project and dissemination of the results.

Members:

Vassili Soumelis (Coordinator of the consortium)INSERM u933

Arturo Hernandez-Cervantes (Project manager of the consortium)


Bruno Fautrel sorbonne universite logo APHP Imidiate
Emna Chabaane      

Fredéric Peyrane LOGO MANDANOVA RVB

 

Project Information ImmunAID | Grant agreement number: 779295

Start date: 1 Mai 2018 | End date: 30 Avril 2023 Funded under: H2020-EU.3.1.1.

Total budget: € 15 835 851,25 | Contribution de l’UE: € 15 835 851,25

Coordinated by: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FRANCE

Countries

12

Countries

Funding

16 M€

Funding

Years

5

Years

Partners

25

Partners

Hospitals

37

Hospitals